Prealbumin Prognostic Score: A Novel Prognostic Indicator After Radical Gastrectomy in Patients with Gastric Cancer

  • 0Department of Gastroenterological Surgery, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

|

|

Summary

This summary is machine-generated.

The novel prealbumin prognostic score (PPS) better predicts overall survival in gastric cancer patients post-surgery than the modified Glasgow Prognostic Score (mGPS). This new score, using prealbumin and CRP, identifies more patients with poor outcomes after gastrectomy.

Area Of Science

  • Oncology
  • Surgical Gastroenterology
  • Biomarker Research

Background

  • Gastric cancer prognosis is often assessed using inflammatory markers.
  • The modified Glasgow Prognostic Score (mGPS) uses albumin and C-reactive protein (CRP).
  • Prealbumin may offer a more sensitive indicator of nutritional status and inflammation.

Purpose Of The Study

  • To evaluate the prealbumin prognostic score (PPS) as a predictive marker in gastric cancer patients.
  • To compare the efficacy of PPS against the established mGPS post-gastrectomy.
  • To determine if PPS improves the identification of patients with poor overall survival (OS).

Main Methods

  • Retrospective analysis of 4663 patients undergoing radical gastrectomy for Stages I-III gastric cancer (2006-2017).
  • Preoperative prealbumin (cutoff 22 mg/dL) and CRP (cutoff 0.5 mg/dL) levels were used to calculate PPS.
  • PPS categories: 0 (both markers above cutoff), 1 (one marker below cutoff), 2 (both markers below cutoff).

Main Results

  • Higher PPS correlated significantly with poorer overall survival (OS) (p < 0.001).
  • PPS of one indicated poorer OS than PPS of zero, even in patients with mGPS of zero (p < 0.001).
  • Multivariate analysis identified PPS 1 (HR 1.603) and PPS 2 (HR 1.322) as independent poor prognostic factors for OS.

Conclusions

  • The prealbumin prognostic score (PPS) effectively predicts overall survival in gastric cancer patients post-gastrectomy.
  • PPS demonstrates superior ability to identify a broader range of patients with poor OS compared to mGPS.
  • PPS, combining prealbumin and CRP, offers a valuable tool for prognostic assessment in gastric cancer management.